(Q59391989)

English

Five-year follow-up of a prospective randomised multi-centre trial of weekly chemotherapy (CAPOMEt) versus cyclical chemotherapy (CHOP-Mtx) in the treatment of aggressive non-Hodgkin's lymphoma. Central Lymphoma Group

scientific article published on 01 June 1998

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9681077%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

Five-year follow-up of a prospective randomised multi-centre trial of weekly chemotherapy (CAPOMEt) versus cyclical chemotherapy (CHOP-Mtx) in the treatment of aggressive non-Hodgkin's lymphoma. Central Lymphoma Group (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9681077%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

1 reference

based on heuristic

inferred from title

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9681077%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

author name string

N P Bailey

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9681077%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

N S Stuart

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9681077%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

E M Bessell

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9681077%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

J A Child

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9681077%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

D Norfolk

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9681077%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

J Fletcher

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9681077%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

R J Grieve

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9681077%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

A V Simmons

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9681077%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

D L Barnard

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9681077%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

A Jack

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9681077%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

J Farish

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9681077%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

C M Woodroffe

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9681077%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

C Stack

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9681077%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

M H Cullen

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9681077%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

publication date

1 June 1998

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9681077%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9681077%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9681077%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9681077%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

633-638

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9681077%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

Long-term remission durability and functional status of patients treated for diffuse histiocytic lymphoma with the CHOP regimen

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008276700860

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification of major prognostic subgroups of patients with large-cell lymphoma treated with m-BACOD or M-BACOD

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008276700860

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized comparison of MACOP-B with CHOP in patients with intermediate-grade non-Hodgkin's lymphoma. The Australian and New Zealand Lymphoma Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008276700860

7 January 2021

based on heuristic

inferred from DOI database lookup

The importance of dose intensity in chemotherapy of metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008276700860

7 January 2021

based on heuristic

inferred from DOI database lookup

MACOP-B chemotherapy for the treatment of diffuse large-cell lymphoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008276700860

7 January 2021

based on heuristic

inferred from DOI database lookup

A pilot study of cyclical chemotherapy with high-dose methotrexate and CHOP (MTX-CHOP) in poor-prognosis non-Hodgkin's lymphoma (NHL)

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008276700860

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved prognosis of diffuse histiocytic and undifferentiated lymphoma by use of high dose methotrexate alternating with standard agents (M-BACOD)

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008276700860

7 January 2021

based on heuristic

inferred from DOI database lookup

Etoposide as a single agent in relapsed advanced lymphomas. A phase II study.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008276700860

7 January 2021

based on heuristic

inferred from DOI database lookup

Updated Kiel classification for lymphomas

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008276700860

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensive and sequential combination chemotherapy for aggressive malignant lymphomas (protocol LNH-80)

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008276700860

7 January 2021

based on heuristic

inferred from DOI database lookup

Superiority of ProMACE-CytaBOM over ProMACE-MOPP in the treatment of advanced diffuse aggressive lymphoma: results of a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008276700860

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008276700860

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of a second-generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008276700860

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomised comparison of a third-generation regimen (PACEBOM) with a standard regimen (CHOP) in patients with histologically aggressive non-Hodgkin's lymphoma: a British National Lymphoma Investigation report

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008276700860

7 January 2021

based on heuristic

inferred from DOI database lookup

Non-Hodgkin's lymphoma in elderly patients: a phase II study of MCOP chemotherapy in patients aged 70 years or over with intermediate- or high-grade histology

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008276700860

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1023/A:1008276700860

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9681077%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9681077%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q59391989&oldid=2080587724"